Allotment of USD 10,000,000 8% Senior Unsecured Foreign Currency COnvertible Bonds Due 2029 of the Company.

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹32.57

prior close

₹34.19

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%+3.9% vs market

Specialty Chemicals peers, median of 92sector+0.0%+5.0% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 5.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.6

15m

-0.6

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+1.1+3.9+0.0+5.0

Next day

+2.9+1.2+1.7+0.2+2.7

+5.9+2.8+3.1+1.4+4.5

+8.2+3.5+4.7+1.4+6.8

+12.2+3.5+8.7+1.5+10.7

+7.6+2.8+4.8+0.6+7.0

+7.0+2.8+4.2+0.0+7.0

15d

+7.5+4.2+3.3+0.5+7.0

+16.4+10.1+6.3+4.4+11.9

+31.4+10.0+21.4+3.0+28.4

+17.3+14.6+2.7+4.9+12.4

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 92Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sudarshan Pharma Industries has allotted 10,000 Foreign Currency Convertible Bonds (FCCBs) worth USD 10 million to subscribers. Each bond has a face value of USD 1,000 with an 8% coupon rate, maturing in 2029. The bonds are convertible into equity shares of the company at a price of Rs. 30.19 per share. The company also has an option to issue an additional USD 10 million of bonds on the same terms within 60 days. The bonds will be credited to subscribers on May 21, 2026, subject to receipt of funds and regulatory compliance.

Likely market impact

Existing shareholders face potential dilution when bondholders convert their FCCBs into equity shares at Rs. 30.19. The foreign currency denomination adds currency risk exposure for investors.